Perkinelmer (PKI)

Company Profile

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.

Company profile

Ticker

PKI

Exchange

NYSE

Website

www.perkinelmer.com

CEO

Prahlad Singh

Incorporated

Massachusetts

Location

Massachusetts

Fiscal year end

Dec 29

Sector

Manufacturing > Analytical Laboratory Instrument Manufacturing

Industry (SIC)

Laboratory Analytical Instruments

Agilent • Bio-Rad Laboratories • Waters • Illumina • Avantor • Mettler-Toledo International • Bruker • Seer • Cue Health • Cytek BioSciences ...

Former names

EG&G INC

SEC CIK

0000031791

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

2Cure, LLC • BioLegend CNS, Inc. • BioLegend Ventures, LLC • BioLegend, Inc. • Caliper Life Sciences, Inc. • Cambridge Research • Dharmacon, Inc. • Horizon Discovery, Inc. • Immunodiagnostic Systems Inc. • Nexcelom Bioscience Holdings, LLC ...

IRS number

42052042

PKI stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$161.00

Low target

$140.00

High target

$182.00

Latest filings (excl ownership)

View all

8-K

Entry into a Material Definitive Agreement

15 Mar 23

ARS

2023 FY

Annual report to shareholders

8 Mar 23

DEFA14A

Additional proxy soliciting materials

8 Mar 23

1 Mar 23

Results of Operations and Financial Condition

14 Feb 23

8-K

Results of Operations and Financial Condition

14 Nov 22

Results of Operations and Financial Condition

8 Nov 22

8-K

Results of Operations and Financial Condition

17 Oct 22

Transcripts

View all

PKI

Earnings call transcript

2022 Q3

8 Nov 22

PKI

Earnings call transcript

2022 Q2

5 Aug 22

PKI

Earnings call transcript

2022 Q1

4 May 22

PKI

Earnings call transcript

2021 Q4

2 Feb 22

PKI

Earnings call transcript

2021 Q3

3 Nov 21

PKI

Earnings call transcript

2021 Q2

29 Jul 21

PKI

Earnings call transcript

2021 Q1

5 May 21

PKI

Earnings call transcript

2020 Q4

3 Feb 21

PKI

Earnings call transcript

2020 Q3

28 Oct 20

PKI

Earnings call transcript

2020 Q2

28 Jul 20

Latest ownership filings

View all

Daniel R Tereau

22 Mar 23

144

Notice of proposed sale of securities

Financial summary

Financial statements Chart PKI financial data

Quarter (USD)	Jan 23	Oct 22	Jul 22	Apr 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Jan 23	Jan 22	Jan 21	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	470.75 mm	470.75 mm	470.75 mm	470.75 mm	470.75 mm	470.75 mm
Cash burn (monthly)	(no burn)	12.38 mm	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	n/a	33.79 mm	n/a	n/a	n/a	n/a
Cash remaining	n/a	436.95 mm	n/a	n/a	n/a	n/a
Runway (months of cash)	n/a	35.3	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from Perkinelmer earnings reports.

Institutional ownership, Q4 2022

PKI institutional ownership history Ownership history

83.8% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	591	530	+11.5%
Opened positions	103	50	+106.0%
Closed positions	42	91	-53.8%
Increased positions	194	175	+10.9%
Reduced positions	187	193	-3.1%

13F shares	Current	Prev Q	Change
Total value	14.84 tn	12.31 bn	+120466.2%
Total shares	105.99 mm	102.29 mm	+3.6%
Total puts	52.00 k	81.60 k	-36.3%
Total calls	43.70 k	95.40 k	-54.2%
Total put/call ratio	1.2	0.9	+39.1%

Largest owners	Shares	Value	Change
Vanguard	14.39 mm	$2.02 tn	+2.3%
Capital Research Global Investors	12.86 mm	$1.80 tn	-10.1%
Select Equity	9.78 mm	$1.37 tn	+11.7%
T. Rowe Price Investment Management	9.40 mm	$1.32 tn	-31.4%
BLK Blackrock	8.47 mm	$1.19 tn	+3.3%
STT State Street	5.26 mm	$737.16 bn	NEW
Massachusetts Financial Services	3.24 mm	$454.77 bn	-18.4%
Pictet Asset Management	3.15 mm	$441.04 bn	+12.4%
Geode Capital Management	2.54 mm	$355.28 bn	+2.2%
T. Rowe Price	2.21 mm	$309.40 bn	-2.3%

Largest transactions	Shares	Bought/sold	Change
STT State Street	5.26 mm	+5.26 mm	NEW
T. Rowe Price Investment Management	9.40 mm	-4.31 mm	-31.4%
Capital Research Global Investors	12.86 mm	-1.45 mm	-10.1%
Norges Bank	1.36 mm	+1.36 mm	NEW
Citadel Advisors	1.28 mm	+1.13 mm	+763.5%
Select Equity	9.78 mm	+1.02 mm	+11.7%
Massachusetts Financial Services	3.24 mm	-733.38 k	-18.4%
Millennium Management	683.32 k	+640.50 k	+1496.0%
Ceredex Value Advisors	611.30 k	+611.30 k	NEW
Robecosam	755.50 k	-372.00 k	-33.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

PKI insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
20 Mar 23	Tereau Daniel R	Common Stock	Sell	Dispose S	No	Yes	124.79	300	37.44 k	11,611
20 Mar 23	Tereau Daniel R	Common Stock	Sell	Dispose S	No	Yes	124.01	5,304	657.75 k	11,911
20 Mar 23	Tereau Daniel R	Common Stock	Sell	Dispose S	No	Yes	123.37	5,122	631.90 k	17,215
20 Mar 23	Tereau Daniel R	Common Stock	Sell	Dispose S	No	Yes	121.69	15	1.83 k	22,337
20 Mar 23	Tereau Daniel R	Common Stock	Option exercise	Acquire M	No	No	52.65	3,750	197.44 k	22,352
20 Mar 23	Tereau Daniel R	NQ Stock Option Common Stock	Option exercise	Dispose M	No	No	52.65	3,750	197.44 k	0
16 Mar 23	Maxwell Krakowiak	Common Stock	Payment of exercise	Dispose F	No	No	122.54	21	2.57 k	7,524
16 Feb 23	Vohra Tajinder S	Common Stock	Grant	Acquire A	No	No	0	2,201	0.00	23,805
16 Feb 23	Vohra Tajinder S	NQ Stock Option Common Stock	Grant	Acquire A	No	No	133.2	6,333	843.56 k	6,333
16 Feb 23	Singh Prahlad R.	Common Stock	Grant	Acquire A	No	No	0	14,272	0.00	83,016